Filter posts

Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI

To even the most casual observer, 2015 has been a big year in the biotech …

WSJ: U.S. Concessions on TPP Means Fewer Cures

Today’s Wall Street Journal editorial, Pacific Trade Brinksmanship, does an outstanding job highlighting the important …

New Report Suggests RDP Does Not Increase Healthcare Expenditures

A new paper by the Geneva Network suggests that increasing the period of regulatory data …

TPP and IP: The Economic Benefits of a Pacific Trade Agreement

Ndp Analytics recently published a study on the economic benefits of intellectual property rights (IP) …

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations …

Bi-partisan Senate Letter asking for 12 years of Data Protection in TPP

Senators Hatch and Kerry, along with 35 other Senators, sent a letter to Ambassador Kirk asking for 12 …

Data Protection, Trans Pacific Partnership, and the US-Jordan FTA (Post 2 of 2)

This post is a continuation of a previous post: Data Protection, the Trans Pacific Partnership, …

Data Protection, the Trans Pacific Partnership, and the US-Jordan FTA (Post 1 of 2)

The Trans Pacific Partnership (TPP) negotiation does not yet include a section on data protection …